Abstract
BackgroundChronic obstructive pulmonary disease (COPD) has been considered a disease of the elderly, but it could also occur in young people aged 20–50 years. However, the characteristics and prognosis of COPD in such young people remain unclear.MethodsOur retrospective cohort study was based on the National Health and Nutrition Examination Survey (NHANES). Participants who 20–50 years old at baseline and completed the pulmonary function test were enrolled in our study cohort. These participants were followed up to 31 December 2019. The sample weight and Taylor Linearization Procedures were adapted to make representative estimations of prevalence and baseline characteristics. The weighted logistic regression model was used to assess the risk factors. The propensity score method and Cox proportional hazard models were applied to calculate the risk of mortality.ResultsThe weighted prevalence of COPD in young people in the USA was 1.64% and it increased with age, with a higher prevalence in males than females (2.59% vs 0.72%, p<0.001). The proportion of Global Initiative for COPD 1–2 was 96.7%. Males (OR=4.56, 95% CI: 2.74 to 7.61), non-Hispanic black (OR=2.77; 95% CI: 1.14 to 6.75), non-Hispanic white (OR=4.93; 95% CI: 2.16 to 11.28) and smoking (current smoking, OR=2.36; 95% CI: 1.40 to 3.98; ever smoking, OR=1.92; 95% CI: 1.05 to 3.51; passive smoking, OR=2.12; 95% CI: 1.41 to 3.20) were shown to be independent risk factors for COPD in young people. Compared with those matched by sex, age and race, the young people with COPD had a higher risk of all-cause death (HR=3.314, p<0.001).ConclusionCOPD in young people has a low prevalence in the USA and its independent risk factors included male, race (non-Hispanic black and non-Hispanic white) and smoking. Young COPD has a higher risk of all-cause mortality than the matched non-COPD.
Funder
Guangzhou National Laboratory
Medical Scientific Research Foundation of Guangdong Province, China
the National Key Technology R&D Program
Subject
Pulmonary and Respiratory Medicine
Reference26 articles.
1. Safiri S , Carson-Chahhoud K , Noori M , et al . Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the global burden of disease study 2019. BMJ 2022;378:e069679. doi:10.1136/bmj-2021-069679
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for prevention, diagnosis and management of COPD: 2022 Reprot; 2022. Available: https://goldcopd.org/2022-gold-reports-2/
3. Treatment trials in young patients with chronic obstructive pulmonary disease and pre-chronic obstructive pulmonary disease patients: time to move forward;Martinez;Am J Respir Crit Care Med,2022
4. At the root: defining and halting progression of early chronic obstructive pulmonary disease;Martinez;Am J Respir Crit Care Med,2018
5. Cosío BG , Pascual-Guardia S , Borras-Santos A , et al . Phenotypic characterisation of early COPD: a prospective case-control study. ERJ Open Res 2020;6:00047-2020. doi:10.1183/23120541.00047-2020